Prognostic value of pretreatment PET/CT lean body mass-corrected parameters in patients with hepatocellular carcinoma

ObjectiveThis study was designed to investigate whether pretreatment fluorine-18-fluorodeoxyglucose (18F-FDG) PET/computed tomography (CT) lean body mass-corrected parameters could predict the overall survival (OS) better than the established predictors in patients with hepatocellular carcinoma (HCC